HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Candida dubliniensis meningitis as delayed sequela of treated C. dubliniensis fungemia.

Abstract
We present a case of Candida dubliniensis meningitis that developed 2 months after apparently successful treatment of an episode of C. dubliniensis candidemia in a heart-lung transplant recipient in Australia. This case highlights the importance of follow-up in patients with candidemia or disseminated infection, especially in immunosuppressed patients.
AuthorsSebastian J van Hal, Damien Stark, John Harkness, Deborah Marriott
JournalEmerging infectious diseases (Emerg Infect Dis) Vol. 14 Issue 2 Pg. 327-9 (Feb 2008) ISSN: 1080-6040 [Print] United States
PMID18258133 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Fluconazole
  • Caspofungin
Topics
  • Antifungal Agents (therapeutic use)
  • Candida (classification, isolation & purification)
  • Candidiasis (complications, drug therapy, microbiology)
  • Caspofungin
  • Echinocandins (therapeutic use)
  • Fluconazole (therapeutic use)
  • Fungemia (complications, drug therapy, microbiology)
  • Heart Transplantation (adverse effects)
  • Humans
  • Lipopeptides
  • Male
  • Meningitis, Fungal (microbiology)
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: